A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Jody Schultz, Yukang Lin, James Sanderson, +5

PubMed

EngineeringB9e9 Monoclonal AntibodyImmunologyGlycobiologyPathology +19

Mechanism and Specificity of Human α-1,3-Fucosyltransferase V

Brion W. Murray, Shuichi Takayama, Jody Schultz, +1

Biochemistry

Synergistic Inhibition of Human α-1,3-Fucosyltransferase V

Lei Qiao, Brion W. Murray, Makoto Shimazaki, +2

Journal of the American Chemical Society

Human α-1,3-Fucosyltransferase VBiosynthesisEngineeringNatural Product SynthesisBiochemistry +12

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts

Meili Zhang, Zhuo Zhang, Kayhan Garmestani, +6

Proceedings of the National Academy of Sciences

Reduced antibody response to streptavidin through site‐directed mutagenesis

Damon L. Meyer, Jody Schultz, Yukang Lin, +6

Protein Science

Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis x oligosaccharide and anti-rat P-selectin antibodies

Shinichiro J. Tojo, Shin‐ichi Yokota, Haruhiko Koike, +7

Glycobiology

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

Scott S. Graves, Erica Dearstyne, Yukang Lin, +8

PubMed

ImmunologyImmunoeditingPathologyImmunotherapyTumor Biology +15

Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice

Michael R. Lewis, Jiuli Zhang, Fang Jia, +8

Nuclear Medicine and Biology

XenotransplantationBiological ComparisonNatural SciencesMolecular BiologyXenograft-bearing Nude Mice +4

Preclinical Evaluation of a Humanized NR-LU-10 Antibody-Streptavidin Fusion Protein for Pretargeted Cancer Therapy

S C Goshorn, James Sanderson, Donald B. Axworthy, +3

Cancer Biotherapy and Radiopharmaceuticals

Immunocytochemical TechniqueImmunologyMolecular BiologyAntigen ProcessingImmunotherapy +18

Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein

Donald J. Buchsbaum, M.B. Khazaeli, Donald B. Axworthy, +5

Clinical Cancer Research